Join RT Magazine on Sept 24th at 2pm ET for a free webinar on reducing and preventing VAE/VAP. Five experts in respiratory care and infectious disease control will discuss research and offer effective and successful strategies.
RT Magazine’s annual Product Guide, which includes more than 60 of the newest respiratory care products from 50 leading manufacturers, is now available on our enhanced mobile application for tablets and smartphones.
The idea of the Ebola virus becoming airborne is not far-fetched and its ability to enter cells that line the trachea and lungs has been shown under controlled laboratory conditions.
The CDC has updated the number of confirmed enterovirus D68 cases to include 140 people in 16 states.
Mylan will conduct a phase 3 clinical trial to evaluate the equivalence of its generic version of Advair Diskus as inhalation treatment in adults with asthma.
Treating insomnia in patients 55+ led to decreases in a known marker of inflammation called C-reactive protein (CRP).
Elderly patients with asthma had greater involvement with small and large airways and less atopy than patients aged 65 years or younger with asthma, according to recent study results.
The first blood test to diagnose major depression in adults has been developed by Northwestern Medicine scientists, a breakthrough approach that provides the first objective, scientific diagnosis for depression.
Boehringer Ingelheim has paid $600M for global commercial rights to CV9202, a cancer vaccine and plans to match it with Gilotrif (afatanib) for non-small cell lung cancer.
Pediatricians prescribe antibiotics about twice as often as they’re actually needed for children with ear and throat infections, a new study indicates.
ResMed’s AirView patient management system is providing clinicians at Fairview Health Services with access to patient PAP therapy data within its EHR system.
New virology research indicates that host cells, which have a natural ability to restrict viral infection, can be used to combat the influenza virus.